Overview

Safety and Efficacity of NFL101 as Tobacco Therapy

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This Phase I study is to investigate the safety of two dose levels of NFL-101 in smokers.
Phase:
Phase 1
Details
Lead Sponsor:
Institut du Cancer de Montpellier - Val d'Aurelle